According to our latest study, “Flowable Hemostats Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Material, Product, Application, and End User,” the market is expected to grow from US$ 304.9 million in 2022 to US$ 458.9 million by 2028; it is estimated to grow at a CAGR of 7.1% from 2022 to 2028. The report highlights the major factors driving the market and prominent players with their developments. The market growth is primarily driven by the increasing injuries and surgical procedures and rising geriatric population. However, poor policies of reimbursement and shortage of skilled professionals hinder the growth of the flowable hemostats market.

Flowable hemostatic agents are thick, flowable consistency products comprising two chief components, active and passive, which convert fibrinogen to fibrin at the site of bleeding. The passive component is either bovine or porcine gelatin, while the active component is thrombin. Thrombin addition to gelatin may not be required in some instances. Flowable hemostats are considered highly efficacious in achieving hemostasis due to the combined effect of these constituents.

Based on material, the flowable hemostats market is bifurcated into bovine gelatin and porcine gelatin. The bovine segment holds a larger market share in 2022 and is anticipated to register a higher CAGR of 7.3% in the market during the forecast period. The market for the bovine gelatin segment is growing due to the rise in the prevalence of chronic cardiac diseases. Bovine gelatin is a protein-based product produced by partial hydrolysis of collagen. The collagen material is extracted from bovine tissue, such as bone and skin. The product has hemostatic properties and is used in admixture with thrombin to provide an excellent hemostat result. The increasing number of general surgeries along with the geriatric population drives the flowable hemostat market growth for the bovine gelatin segment. In addition, building advanced healthcare infrastructure in developing countries, including China and India, is another factor assisting the growth of the market.

Get a Sample Copy: https://www.theinsightpartners.com/sample/TIPRE00015216/

Flowable hemostats have flowable consistency and contain a porcine or bovine gelatin matrix. It may add topical thrombin. When an application is needed on a difficult reach surface or in a wet field flowable hemostats are helpful. The product can be used for all surgical procedures except ophthalmic.

 The flowable hemostats market is majorly comprised of top players involving Baxter International, Ethicon (Johnson and Johnson Services, Inc.), Pfizer Inc., Teleflex Incorporated, B. Barun, BD, SYMATESE amongst others.

The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the Europe, China, and Japan market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.

Below is the list of the growth strategies done by the players operating in the flowable hemostats market:

ABOUT US:

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact US:

If you have any queries about this report or would like further information, please contact us:

North America:          +1 646 491 9876
Asia-Pacific:               +91 20 6727 8686
Email:                         sales@theinsightpartners.com